References
- Intuniv® [package insert]. Wayne, PA: Shire US Inc.; 2009.
- Hunt RD, Arnsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34:50–54.
- Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007–1022.
- Guanfacine. In: DRUGDEX® System (electronic version). Truven Health Analytics, Ann Arbor, MI. [cited 2017 Jun 30]. Available at: http://www.micromedexsolutions.com/
- Guanfacine. In: POISINDEX® System (electronic version). Truven Health Analytics, Ann Arbor, MI. [cited 2017 Jun 30]. Available at: http://www.micromedexsolutions.com/
- McGrath JC, Klein-Schwartz W. Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother. 2002;36:1698–1703.
- Wang GS, Le Lait MC, Heard K. Unintentional pediatric exposures to central alpha-2 agonists reported to the National Poison Data System. J Pediatr. 2014;164:149–152.
- Guanfacine. In: Lexi-Tox™ (electronic version). Wolters Kluwer Clinical Drug Information, Inc., Hudson, OH. [cited 2019 Jan 25]. Available at: https://online.lexi.com/lco/action/home/tox
- Minns AB, Clark RC, Schneir A. Guanfacine overdose resulting in initial hypertension and subsequent delayed persistent orthostatic hypotension. Clin Toxicol. 2010;48:146–148.
- Spiller HA, Hays HL, Aleguas A. Jr., Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 2013;27:531–543.
- Rangan C, Poisoning & drug overdose. 7th ed. New York, NY: McGraw-Hill; 2018. Section II: specific poisons and drugs: diagnosis and treatment, clonidine and related drugs.
- Tsze DS, Dayan PS. Treatment of guanfacine toxicity with naloxone. Pediatr Emerg Care. 2012;28:1060–1061.
- American Association of Poison Control Centers. National Poison Data System Coding Users’ Manual. Version 3.2. Feb 2016.
- Boellner SW, Pennick M, Fiske K, et al. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Pharmacotherapy. 2007;27:1253–1262.